ARQT
Arcutis Biotherapeutics, Inc.Healthcare$23.63
▲ Bullish
Mkt Cap: $2.93B|Float: 91.9M|SI: 17.1%|DTC: 11.3
Data as of market close Apr 2, 2026
IV Rank
41
IV Pctl
44%
HV 20d
48.7%
52W Range
$12-$32
ATR(14)
$1.04
Exp. Move
±21.8%
P/C Ratio
0.19
Earnings
May 5
GEX Positive
DEX Long
Net Call Premium
IV Moderate
Max Pain Below
Exp. Move Wide
Low Put/Call
ARQT Key Options Data
- IV Rank
- 40.5%
- Total GEX
- $0.00B
- Total DEX
- $0.4M
- Max Pain
- $22.50
- Expected Move
- ±21.8%
- Put/Call OI
- 0.19
- Net Premium
- $0.6M
- Spot Price
- $23.63
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$5.15 | ±21.8% | $18.48 | $28.78 |
| 2026-05-15 | 43 | ±$2.40 | ±10.2% | $21.23 | $26.03 |
| 2026-06-18 | 77 | ±$6.40 | ±27.1% | $17.23 | $30.03 |
| 2026-09-18 | 169 | ±$9.20 | ±38.9% | $14.43 | $32.83 |
| 2027-01-15 | 288 | ±$10.95 | ±46.3% | $12.68 | $34.58 |
Explore ARQT options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.